Metabolomics generates a profile of small molecules that are derived from cellular metabolism and can directly reflect the outcome of complex networks of biochemical reactions, thus providing insights into multiple aspects of cellular physiology. Technological advances have enabled rapid and increasingly expansive data acquisition with samples as small as single cells; however, substantial challenges in the field remain. In this primer we provide an overview of metabolomics, especially mass spectrometry (MS)-based metabolomics, which uses liquid chromatography (LC) for separation, and discuss its utilities and limitations. We identify 
quantitative in that the number of molecules in the sample corresponds to the number of nuclei in that sample, although this limitation in MS can be overcome by incorporating internal standards before extraction. Both LC and gas chromatography (GC) are used for metabolite separation (Table 1) . Efforts have also been made to combine these different instruments (LC-NMR-MS) to advance structure elucidation [ 4 5 7 _ T D $ D I F F ] [28] . In addition, the amount of material required for metabolomics is becoming smaller, which allows single-cell metabolite profiling or spatial resolution within cells or tissues. However, data collection is merely the first step of metabolomics, and metabolomics is ultimately an integration of instrumentation, chemistry, statistics, and computer science with a biological problem [ 4 5 8 _ T D $ D I F F ] [4, 30, 31] . Here we provide a primer on metabolomics discussing its process, the types of data that are obtained, and its applications.
From Experiment to MS Data: Sample Preparation and Instrumentation
There is no limitation on the sample types that are suitable for a metabolomics study. However, the sample type and metabolites of interest determine the appropriate sample preparation procedures [ 4 5 9 _ T D $ D I F F ] [32] [33] [34] . Furthermore, data interpretation differs markedly depending on the biological system from which the metabolites originated. For example, to compare health and disease states or to study drug actions, measuring the level of a metabolite in the serum may be a reasonable proxy for a physiological function [ 4 6 0 _ T D $ D I F F ] [35] since the serum metabolome is the net effect of diet, environment, and the whole-body response to a disease or a drug. However, measuring the same metabolite level in a tissue would require a different interpretation, because it more reflects the cell-autonomous effect. In sample preparation procedures, a general principle is to preserve the original state of the biological system as much as possible by minimizing the amount of enzyme activity and chemical reactivity that occurs during metabolite extraction -the process of isolating or purifying metabolites from the original biological matrix (e.g., cells, serum, tissue).
For small-molecule metabolites, protein precipitation or liquid-liquid extraction are the most commonly used methods. Polar organic solvents such as methanol, acetonitrile, or isopropanol are used to extract mostly polar metabolites, whereas relatively non-polar solvents such as hexane, chloroform, or methyl tertiary butyl ether, or combinations of polar and non-polar solvents, are used to extract lipids [ 4 6 1 _ T D $ D I F F ] [36, 37] . Occasionally, acid is added to the extraction solvent to preserve the stability of certain compounds, such as acyl-coenzyme A (CoA) compounds [ 4 6 2 _ T D $ D I F F ] [38] . However, although acidic solvents may stabilize one class of metabolites they may also simultaneously cause degradation of other types of metabolites and possibly cause an overall reduction in the sensitivity of the experiment due to ion suppression [ 4 6 3 _ T D $ D I F F ] [39, 40] For instance, these general protocols may not offer the best sensitivity for every metabolite and therefore unstable or low-abundance metabolites may require special care.
MS involves first ionizing the molecules (i.e., adding a positive or negative charge to them) and then moving these molecules through electric fields where they are eventually analyzed. At each time point, the data are recorded as mass spectra comprising the mass-to-charge ratio (m/z) for each intact ion and corresponding intensity. Each ion has a retention time (RT) and mass spectrum, the values of which are dependent on the instrumental setup. . The first quadrupole filters ions (parent ion) within a defined molecular weight (usually with a resolution of 1 atomic mass unit). The second quadrupole fragments the molecules that have been selected and the third quadrupole selects characteristic fragments. Therefore, before any data acquisition, the parent and fragment ions must be defined and the optimized energy for the fragmentation and RT for each metabolite is needed.
Another increasingly common method for MS is HRMS. These approaches rely on the high mass resolution of the mass analyzer. One commonly used mass analyzer is the Orbitrap TM , which records the oscillation of ions, the frequency of which provides information on the molecular mass [ 4 6 6 _ T D $ D I F F ] [44] . Another is a time-of-flight (TOF) instrument, which records the time it takes for an ion to traverse an electric field [ 4 6 7 _ T D $ D I F F ] [45, 46] . These mass analyzers greatly simplify compound identification compared with lower-resolution methods. When high-resolution mass analyzers are coupled to collision cells, which can fragment ions before they are sent to the mass analyzer, the fragment pattern of ions provides additional structural information. Then, at the data-processing stage, metabolite assignments are made.
From MS Data to Metabolite Profiling
There are numerous open-source and commercial software [ 4 6 8 _ T D $ D I F F ] packages available for raw MS data analysis ( Table 2 ). The output data includes peaks with specific RT and m/z; peak area is usually the preferred parameter to represent the relative abundance of each metabolite in different samples. These software packages typically involve chromatographic alignment, peak selection, and compound identification by searching against metabolomics databases. This untargeted experiment is relatively thorough and unbiased but usually produces thousands of features and, unfortunately, these features do not directly reflect metabolite identity ( Figure Converting ion intensity to metabolite concentration is complex, depending on variables such as the percentage of the compound recovered from the original material, the column binding capacity, the ionization efficiency, and the transmission efficiency through the mass spectrometer. However, MS-based metabolomics data are often semiquantitative, which means that although the signal itself (metabolite peak area) does not reflect the absolute concentration, differences in peak area do scale linearly with metabolite concentration. A differential analysis provides the relevant biological information.
Normalization may be required in certain cases. 
Analysis of a Metabolomics Experiment
Since metabolomics experiments typically contain information that could otherwise be obtained from hundreds of separate biochemical assays, usually some preexisting biological knowledge helps with the interpretation of a metabolomics experiment. Under this framework one can simply use the data to ask biologically relevant questions and make conclusions following the standard scientific method. Such questions could be as follows. Does the energy status change under this condition? What about the redox status? Are the nucleotide levels maintained when this gene is overexpressed? Treating a metabolomics experiment with this mindset often allows one to reach conclusions about a biological mechanism in a highly expedited fashion as opposed to pursuing these hypotheses one by one with separate assays.
Nevertheless, it is not humanly possible to process the entirety of the data from intuition alone. Computational tools are needed for further analysis. Software for feature extraction (Table 2) often include additional data analysis functions, such as principal components analysis and hierarchical clustering, and numerous statistical tests and data visualization plots to identify the largest-changing features and specific signatures in the data. Pathway-enrichment analyses, . These tools become more powerful on integration with other omics data and allow the user to find regions of the metabolic network that correspond to a phenotype or are altered in a condition.
Isotope Tracing, Flux Analysis, and Computational Modeling
The overall metabolite profile is informative in many cases as discussed above, but for metabolites involved in multiple catabolic and anabolic pathways, metabolite levels reflect some complicated conglomeration of each individual pathway contribution. An appropriately designed isotopic tracing study is then used to identify the activity within each pathway of that metabolite and is the phenotypic readout of metabolism. The isotopic labeling pattern of downstream metabolites is used to represent the metabolic flux from different sources. Typical protocols involve incubating a stable isotope-labeled nutrient (such as glucose, an amino acid, a lipid, or other molecules) at the same concentration as the original experiment (different concentrations will induce changes to metabolism from the original condition of interest) and waiting for the metabolic flux to reach steady state . These techniques are collectively termed 'metabolic flux analysis' and involve taking a series of isotope measurements of different metabolites, overlaying them onto a metabolic network, and fitting a mathematical model of the fluxes onto the network that best fits the data. This approach is powerful but at present the implementation of the technology has been limited and most computations involving flux estimation and statistical analysis of the results are typically conducted on an ad hoc basis. Future directions will involve successfully implementing these approaches to serve a broader audience. More detailed discussions about flux calculations have been covered by previous reviews and we refer the reader to these 
Recent Biological Insights Obtained [ 6 0 4 _ T D $ D I F F ] From Metabolomics
In recent years metabolomics has been applied in multiple fields to make new discoveries and confirm hypotheses (Figure 2) . A seminal advance in cancer biology used untargeted LC-HRMS to discover that cancer cells with mutant IDH1 produce 2-hydroxyglutarate, a metabolite that was found in the spectra of the mutants but not the wild-type cells after untargeted metabolomics using LC-HRMS. This metabolite was later shown to provide a link between metabolism and epigenetics . Surprisingly, numerous genetic loci associated with blood metabolite concentrations were discovered and the locations of these loci, for the most part, were in proximity to a gene encoding a metabolic enzyme involved in the production or consumption of the given metabolite. This analysis provided evidence that some of the metabolome variation observed across individuals may be directly encoded in the genome. Such studies may be valuable for the understanding of personalized nutrition, which is still in its infant stages
Flux analyses have also led to important advances in cancer biology. One example is the discovery of the diversion of glycolytic flux into de novo serine metabolism as an important process in some cancers. Further efforts to trace the fate of serine using stable isotopes, 
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Concluding Remarks: Challenges and Future Directions in Metabolomics
In summary, much progress in metabolomics has been made and obtaining a metabolite profile or measuring metabolic flux is now standard practice. Efforts are also being made to advance the field by covering more metabolites with less material or effort, achieving spatial resolution, and the integration of multiomics (Figure 3) . Nevertheless, challenges remain in multiple areas. The greatest challenge for metabolomics is how to best obtain biological insight with the appropriate experimental design. Success often achieves a balance of biological intuition that is supplemented with computation. Choice of experimental model is an essential component in this process. For example, ex vivo systems that can successfully model in vivo metabolism are important -90] . Conclusions drawn from cell culture have substantially advanced biomedical knowledge but must be assessed with respect to the assumptions in the model, such as the nutrient-rich environments that typical culture conditions constitute. Another major challenge is subcellular compartmentalization, as metabolomics data reflect the sum of metabolites in various cellular organelles. Although it would be preferable to assay metabolites from specific organelles, it is very challenging, if currently impossible, to separate organelles while preserving the metabolic state of these structures. Recent studies have used clever isotope tracing strategies to probe cofactors that occur in a specific compartment such as the cytosol These technologies in principle can achieve submicrometer spatial resolution and therefore metabolomics imaging and analysis of subcellular organelles can be achieved. However, with this extremely fine spatial resolution the data acquisition time and data size are also dramatically increased, which makes it difficult to perform single-cell metabolomics in a high-throughput fashion. In addition, efforts are also required to improve the robustness, number of metabolites covered, and accuracy. Therefore, standard metabolomics techniques that average cells remain the mainstay.
Advanced instrumentaƟon Faster algorithms
Better approaches to standardize metabolomics data are also essential to advance the field. Thus, efforts are under way to create better normalization procedures and better protocols to rapidly obtain absolute metabolite concentration values [ 5 0 7 _ T D $ D I F F ] [103, 104] . For flux analysis the mathematical frameworks and algorithms are well beyond what is typically implemented and accessible by the larger community. Efforts to further disseminate these capabilities will prove valuable. Nevertheless, current metabolomics technologies coupled with interesting questions already allow rapid inroads to be made. 
